Your browser doesn't support javascript.
loading
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.
Simon, F; Ligtvoet, R; Nösslinger, T; Bohn, J; von Tresckow, J; Liersch, R; Gaska, T; Jentsch-Ullrich, K; Koenigsmann, M; Wolff, T; Schwaner, I; Wolf, D; Schneider, C; Tausch, E; Stilgenbauer, S; Kreuzer, K; Robrecht, S; Fink, A; Fürstenau, M; Fischer, K; Goede, V; Hallek, M; Eichhorst, B.
Afiliación
  • Simon F; Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf, German CLL Study Group, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Ligtvoet R; Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf, German CLL Study Group, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Nösslinger T; Hanusch Krankenhaus Wien, 3rd Medical Department for Hematology and Oncology, Vienna, Austria.
  • Bohn J; Internal Medicine V, Department of Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck, Innsbruck, Austria.
  • von Tresckow J; Clinic for Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Liersch R; Gemeinschaftspraxis für Hämatologie und Onkologie, Clemenshospital Münster, Münster, Germany.
  • Gaska T; Brüderkrankenhaus St. Josef Paderborn, Klinik für Hämatologie und Onkologie, Paderborn, Germany.
  • Jentsch-Ullrich K; Gemeinschaftspraxis für Hämatologie und Onkologie, Magdeburg, Germany.
  • Koenigsmann M; Onkologisches Ambulanzzentrum Hannover, Hannover, Germany.
  • Wolff T; OncoResearch Lerchenfeld, Hamburg, Germany.
  • Schwaner I; Onkologische Schwerpunktpraxis Kurfürstendamm, Berlin, Germany.
  • Wolf D; Internal Medicine V, Department of Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck, Innsbruck, Austria.
  • Schneider C; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Tausch E; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Stilgenbauer S; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Kreuzer K; Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf, German CLL Study Group, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Robrecht S; Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf, German CLL Study Group, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Fink A; Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf, German CLL Study Group, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Fürstenau M; Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf, German CLL Study Group, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Fischer K; Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf, German CLL Study Group, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Goede V; Department of Oncogeriatrics, St. Marien-Hospital, Cologne, Germany.
  • Hallek M; Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf, German CLL Study Group, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Eichhorst B; Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf, German CLL Study Group, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
Hematol Oncol ; 41 Suppl 2: 468-469, 2023 Jun.
Article en En | MEDLINE | ID: mdl-39112227
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Hematol Oncol Año: 2023 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Hematol Oncol Año: 2023 Tipo del documento: Article País de afiliación: Alemania